UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice

PloS one, 2019-04, Vol.14 (4), p.e0215321-e0215321

2019

Volltextzugriff (PDF)

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

Emerging infectious diseases, 2007-03, Vol.13 (3), p.426-435

2007

Volltextzugriff (PDF)

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses

PloS one, 2010-10, Vol.5 (10), p.e13162-e13162

2010

Volltextzugriff (PDF)

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses

Vaccine, 2009-11, Vol.27 (47), p.6512-6521

2009

Volltextzugriff (PDF)

Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice

PloS one, 2016-04, Vol.11 (4), p.e0153195-e0153195

2016

Volltextzugriff (PDF)

Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus

PloS one, 2013-03, Vol.8 (3), p.e55435-e55435

2013

Volltextzugriff (PDF)

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice

PloS one, 2011-07, Vol.6 (7), p.e21937-e21937

2011

Volltextzugriff (PDF)

Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies

Journal of virology, 2022-05, Vol.96 (12), p.e0032022-e0032022

2022

Volltextzugriff (PDF)

Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination

Journal of virology, 2023-10, Vol.97 (10), p.e0067423-e0067423

2023

Volltextzugriff (PDF)

Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice

Vaccine, 2021-07, Vol.39 (33), p.4628-4640

2021

Volltextzugriff (PDF)

Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model

Journal of virology, 2014-06, Vol.88 (11), p.6019-6030

2014

Volltextzugriff (PDF)

Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen

Vaccine, 2018-08, Vol.36 (32), p.4910-4918

2018

Volltextzugriff (PDF)

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model

Journal of virology, 2021-04, Vol.95 (9)

2021

Volltextzugriff (PDF)

Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic

Open forum infectious diseases, 2017, Vol.4 (2), p.ofx023-ofx023

2017

Volltextzugriff (PDF)

Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice

Vaccine, 2018-02, Vol.36 (7), p.1008-1015

2018

Volltextzugriff (PDF)

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein

Vaccine, 2005-11, Vol.23 (46), p.5404-5410

2005

Volltextzugriff (PDF)

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies

Vaccine, 2008-04, Vol.26 (17), p.2062-2072

2008

Volltextzugriff (PDF)

Genetic control of immune responses to influenza A matrix 2 protein (M2)

Vaccine, 2010-08, Vol.28 (36), p.5817-5827

2010

Volltextzugriff (PDF)

Intranasal Administration of Adeno-associated Virus Type 12 (AAV12) Leads to Transduction of the Nasal Epithelia and Can Initiate Transgene-specific Immune Response

Molecular therapy, 2011-11, Vol.19 (11), p.1990-1998

2011

Volltextzugriff (PDF)

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice

Emerging infectious diseases, 2002-08, Vol.8 (8), p.796-801

2002

Volltextzugriff (PDF)

Mechanism of Protective Immunity Against Influenza Virus Infection in Mice Without Antibodies

The Journal of immunology (1950), 1998-01, Vol.160 (1), p.322-327

1998

Volltextzugriff (PDF)

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice

Emerging infectious diseases, 2002-08, Vol.8 (8), p.796-801

2002

Volltextzugriff (PDF)

Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells

The Journal of immunology (1950), 2001-06, Vol.166 (12), p.7437-7445

2001

Volltextzugriff (PDF)

Susceptibility and immunity to influenza A strains in Ig−/−mice

International Congress series, 2001-10, Vol.1219, p.327-332

2001

Volltextzugriff (PDF)

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge

International immunology, 2000-01, Vol.12 (1), p.91-101

2000

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Mice
(20)
Life Sciences & Biomedicine
(19)
Animals
(18)
Influenza
(17)
Immunology
(14)
Influenza Vaccines - Immunology
(14)
Orthomyxoviridae Infections - Prevention & Control
(13)
Vaccines
(13)
Mice, Inbred Balb C
(12)
Viruses
(12)
Female
(11)
Adenoviruses
(10)
Orthomyxoviridae Infections - Immunology
(10)
Antibodies, Viral - Blood
(9)
Virology
(9)
Antigens
(8)
Immunization
(8)
Influenza A Virus, H1n1 Subtype - Immunology
(8)
Medicine, Research & Experimental
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses

Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice

Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice

Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies

Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination

Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice

Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model

Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model

Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic

Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies

Genetic control of immune responses to influenza A matrix 2 protein (M2)

Intranasal Administration of Adeno-associated Virus Type 12 (AAV12) Leads to Transduction of the Nasal Epithelia and Can Initiate Transgene-specific Immune Response

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice

Mechanism of Protective Immunity Against Influenza Virus Infection in Mice Without Antibodies

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice

Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells

Susceptibility and immunity to influenza A strains in Ig−/−mice

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge

Suchergebnisse filtern